A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer

Recruiting now

Conditions studied: Advanced Breast Cancer

In brief

A prospective, multicenter, observational cohort study assessing the efficacy and safety of radiotherapy-sensitized immunotherapy in advanced breast cancer.

Key facts

Study ID
NCT06776861
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
People needed
150
Starts
2024-09-24
Expected to finish
2028-09-10
Last updated by the study team
2026-06-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.